Below are the most recent publications written about "Premenopause" by people in Profiles.
-
Dillon GA, Harvey RE, Limberg JK, Nicholson WT, Joyner MJ, Baker SE, Miller VM, Ranadive SM. Acute exogenous oestradiol augments endothelial and smooth muscle vasodilatory responsiveness in premenopausal but not postmenopausal females. J Physiol. 2025 04; 603(8):2301-2311.
-
Shenouda N, Stock JM, Chouramanis NV, Lincoln ZR, Wenner MM, Chirinos JA, Edwards DG. Favorable alterations in ventricular-arterial interactions across the menstrual cycle in healthy premenopausal women. Am J Physiol Heart Circ Physiol. 2025 03 01; 328(3):H648-H657.
-
McGinty SJ, Matthews EL, Greaney JL, Shoemaker JK, Wenner MM. Sympathetic baroreflex sensitivity is enhanced in postmenopausal women. J Appl Physiol (1985). 2024 08 01; 137(2):374-381.
-
Baek SY, Noh WC, Ahn SH, Kim HA, Ryu JM, Kim SI, Lee EG, Im SA, Jung Y, Park MH, Park KH, Kang SH, Jeong J, Park E, Kim SY, Lee MH, Kim LS, Lim W, Kim S, Kim HJ. Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor-Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial. J Clin Oncol. 2023 11 01; 41(31):4864-4871.
-
Kalinsky K, Barlow WE, Gralow JR, Meric-Bernstam F, Albain KS, Hayes DF, Lin NU, Perez EA, Goldstein LJ, Chia SKL, Dhesy-Thind S, Rastogi P, Alba E, Delaloge S, Martin M, Kelly CM, Ruiz-Borrego M, Gil-Gil M, Arce-Salinas CH, Brain EGC, Lee ES, Pierga JY, Bermejo B, Ramos-Vazquez M, Jung KH, Ferrero JM, Schott AF, Shak S, Sharma P, Lew DL, Miao J, Tripathy D, Pusztai L, Hortobagyi GN. 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer. N Engl J Med. 2021 12 16; 385(25):2336-2347.
-
D'Agata MN, Hoopes EK, Berube FR, Hirt AE, Kuczmarski AV, Ranadive SM, Wenner MM, Witman MA. Evidence of reduced peripheral microvascular function in young Black women across the menstrual cycle. J Appl Physiol (1985). 2021 12 01; 131(6):1783-1791.
-
Kim HJ, Noh WC, Lee ES, Jung YS, Kim LS, Han W, Nam SJ, Gong G-, Kim HJ, Ahn SH. Efficacy of neoadjuvant endocrine therapy compared with neoadjuvant chemotherapy in pre-menopausal patients with oestrogen receptor-positive and HER2-negative, lymph node-positive breast cancer. Breast Cancer Res. 2020 05 27; 22(1):54.
-
Harvey RE, Ranadive SM, Limberg JK, Baker SE, Nicholson WT, Curry TB, Barnes JN, Joyner MJ. Forearm vasodilatation to a ?2 -adrenergic receptor agonist in premenopausal and postmenopausal women. Exp Physiol. 2020 05; 105(5):886-892.
-
Shah AN, Metzger O, Bartlett CH, Liu Y, Huang X, Cristofanilli M. Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer in Young Women: Emerging Data in the Era of Molecularly Targeted Agents. Oncologist. 2020 06; 25(6):e900-e908.
-
Kim M, Kim H, Ahn SH, Tabatabaie V, Choi SW, Sohn G, Lee SB, Ko BS, Chung IY, Kim J, Lee JW, Son BH, Kim HJ. Changes in bone mineral density during 5?years of adjuvant treatment in premenopausal breast cancer patients. Breast Cancer Res Treat. 2020 Apr; 180(3):657-663.